78 related articles for article (PubMed ID: 1607802)
1. [HTLV-I-associated myelopathy].
Osame M
Nihon Naika Gakkai Zasshi; 1992 Mar; 81(3):389-92. PubMed ID: 1607802
[No Abstract] [Full Text] [Related]
2. [The clinical features of HTLV-I infection. HTLV-I associated myelopathy].
Nakagawa M; Izumo S; Ikurou M; Osame M
Uirusu; 1992 Jun; 42(1):21-8. PubMed ID: 1413532
[No Abstract] [Full Text] [Related]
3. [HTLV-I-associated myelopathy (HAM)].
Osame M
Tanpakushitsu Kakusan Koso; 1990 May; 35(7 Suppl):1320-6. PubMed ID: 2356333
[No Abstract] [Full Text] [Related]
4. [Diagnosis and treatment of HTLV-I associated myelopathy].
Osame M
Nihon Naika Gakkai Zasshi; 1990 Mar; 79(3):261-5. PubMed ID: 2332679
[No Abstract] [Full Text] [Related]
5. Spastic paraparesis associated with human T-lymphotropic virus type I: a clinical, serological, and genomic study in Iranian-born Mashhadi Jews.
Achiron A; Pinhas-Hamiel O; Doll L; Djaldetti R; Chen A; Ziv I; Avni A; Frankel G; Melamed E; Shohat B
Ann Neurol; 1993 Nov; 34(5):670-5. PubMed ID: 8239561
[TBL] [Abstract][Full Text] [Related]
6. Tropical spastic paraparesis and HTLV-I myelopathy: clinical features and pathogenesis.
Rodgers-Johnson PE; Ono SG; Asher DM; Gibbs CJ
Res Publ Assoc Res Nerv Ment Dis; 1990; 68():117-30. PubMed ID: 2183307
[No Abstract] [Full Text] [Related]
7. Human T-lymphotropic virus type I (HTLV-I) and tropical spastic paraparesis or HTLV-I-associated myelopathy in Hawaii.
Dixon PS; Bodner AJ; Okihiro M; Milbourne A; Diwan A; Nakamura JM
West J Med; 1990 Mar; 152(3):261-7. PubMed ID: 2139754
[TBL] [Abstract][Full Text] [Related]
8. Disability profile of patients with HTLV-I-associated myelopathy/tropical spastic paraparesis using the Functional Independence Measure (FIM).
Franzoi AC; Araújo AQ
Spinal Cord; 2005 Apr; 43(4):236-40. PubMed ID: 15520834
[TBL] [Abstract][Full Text] [Related]
9. [HTLV-I-associated myelopathy].
Osame M
Ryoikibetsu Shokogun Shirizu; 1999; (24 Pt 2):41-5. PubMed ID: 10201131
[No Abstract] [Full Text] [Related]
10. HTLV-1-associated myelopathy/tropical spastic paraparesis accompanied with psoriasis.
Watanabe A; Kawajiri M; Ikezoe K; Osoegawa M; Murai H; Ochi H; Taniwaki T; Kira J
J Neurol Sci; 2004 Jun; 221(1-2):95-7. PubMed ID: 15178221
[TBL] [Abstract][Full Text] [Related]
11. Decreased human T lymphotropic virus type I (HTLV-I) provirus load and alteration in T cell phenotype after interferon-alpha therapy for HTLV-I-associated myelopathy/tropical spastic paraparesis.
Saito M; Nakagawa M; Kaseda S; Matsuzaki T; Jonosono M; Eiraku N; Kubota R; Takenouchi N; Nagai M; Furukawa Y; Usuku K; Izumo S; Osame M
J Infect Dis; 2004 Jan; 189(1):29-40. PubMed ID: 14702150
[TBL] [Abstract][Full Text] [Related]
12. HTLV-I serostatus of mothers of patients with adult T-cell leukemia and HTLV-I-associated myelopathy/tropical spastic paraparesis.
Bartholomew C; Jack N; Edwards J; Charles W; Corbin D; Cleghorn FR; Blattner WA
J Hum Virol; 1998; 1(4):302-5. PubMed ID: 10195256
[TBL] [Abstract][Full Text] [Related]
13. Prevalence of peripheral neuropathy in patients with HTLV-1 associated myelopathy/tropical spastic paraparesis (HAM/TSP).
Saeidi M; Sasannejad P; Foroughipour M; Shahami S; Shoeibi A
Acta Neurol Belg; 2011 Mar; 111(1):41-4. PubMed ID: 21510232
[TBL] [Abstract][Full Text] [Related]
14. [Treatment of HTLV-I-associated myelopathy with alpha-interferon and high-dose of gamma-globulin].
Kuroda Y; Takashima H; Endo C; Neshige R; Kakigi R
Rinsho Shinkeigaku; 1990 Jun; 30(6):594-8. PubMed ID: 1699697
[TBL] [Abstract][Full Text] [Related]
15. [Seroprevalence of HTLV-I in relatives of patients with spastic paraparesis (HAM/TSP and PEP)].
Cartier L; Vergara C; Ramírez E; Casivar T; Vásquez A
Rev Med Chil; 1995 Jan; 123(1):7-11. PubMed ID: 7569448
[TBL] [Abstract][Full Text] [Related]
16. Juvenile human T lymphotropic virus type 1-associated myelopathy.
Araújo AP; Fontenelle LM; Pádua PA; Maia Filho HS; Araújo Ade Q
Clin Infect Dis; 2002 Jul; 35(2):201-4. PubMed ID: 12087528
[TBL] [Abstract][Full Text] [Related]
17. Recent studies on the epidemiology, clinical features and pathogenic mechanisms of HTLV-I associated myelopathy (HAM/TSP) and other diseases associated to HTLV.
Osame M; Nakagawa M; Umehara F; Ijichi S; Moritoyo T; Higuchi I; Usuku K; Arimura K; Izumo S
J Neurovirol; 1997 May; 3 Suppl 1():S50-1. PubMed ID: 9179793
[No Abstract] [Full Text] [Related]
18. Evaluation of host genetic and viral factors as surrogate markers for HTLV-1-associated myelopathy/tropical spastic paraparesis in Peruvian HTLV-1-infected patients.
Talledo M; López G; Huyghe JR; Verdonck K; Adaui V; González E; Best I; Clark D; Vanham G; Gotuzzo E; Van Camp G; Van Laer L
J Med Virol; 2010 Mar; 82(3):460-6. PubMed ID: 20087941
[TBL] [Abstract][Full Text] [Related]
19. Systemic interferon-alpha in the treatment of HTLV-I-associated myelopathy.
Kuroda Y; Kurohara K; Fujiyama F; Takashima H; Endo C; Matsui M; Neshige R; Kakigi R
Acta Neurol Scand; 1992 Jul; 86(1):82-6. PubMed ID: 1519481
[TBL] [Abstract][Full Text] [Related]
20. Ocular manifestations in patients with HTLV-I associated infection--a clinical study of 93 cases.
Merle H; Smadja D; Le Hoang P; Bera O; Cabre P; Landau M; Vernant JC
Jpn J Ophthalmol; 1996; 40(2):260-70. PubMed ID: 8876397
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
